We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Certolizumab pegol (rbe)
Australian Public Assessment Report
Device/Product Name
Cimzia
Active ingredients
Certolizumab pegol (rbe)
AusPAR Date
Published
Sponsor
Submission Number
PM-2018-04256-1-3
Submission Type
Extension of indications
Decision
Approved